Phase 2 Xerostomia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Radiation-Induced Xerostomia and Hyposalivation
RiboX Therapeutics Ltd.42 enrolled4 locationsNCT06714253
Recruiting
Phase 2
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
MeiraGTx, LLC276 enrolled33 locationsNCT05926765
Recruiting
Phase 1Phase 2
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
Radiation-induced Xerostomia
West China Hospital58 enrolled1 locationNCT07035626
Completed
Phase 2
A study of the safety and efficacy of LBS-020 in patients with mouth dryness following radiotherapy
Xerostomia
Lubris LLC50 enrolled2 locationsACTRN12619000593134
Terminated
Phase 2
Single patient multiple cross-over trials to determine the efficacy of pilocarpine 5 mg orally dissolving tablets in patients suffering from dry mouth.
Xerostomia
University of Queensland32 enrolled1 locationACTRN12617001067369